These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 37963604)
21. Additive renal effects of indomethacin and dipyridamole in man. Seideman P; Sollevi A; Fredholm BB Br J Clin Pharmacol; 1987 Mar; 23(3):323-30. PubMed ID: 3567047 [TBL] [Abstract][Full Text] [Related]
22. [Indomethacin and furosemide in closure of ductus arteriosus]. Vargas-Origel A; Cruz-Anguiano V; López-Montaño E Bol Med Hosp Infant Mex; 1986 Aug; 43(8):482-8. PubMed ID: 3755939 [No Abstract] [Full Text] [Related]
23. Oligohydramnios, renal insufficiency, and ileal perforation in preterm infants after intrauterine exposure to indomethacin. Vanhaesebrouck P; Thiery M; Leroy JG; Govaert P; de Praeter C; Coppens M; Cuvelier C; Dhont M J Pediatr; 1988 Oct; 113(4):738-43. PubMed ID: 3050004 [TBL] [Abstract][Full Text] [Related]
24. Renal effects of indomethacin in patients with systemic lupus erythematosus. ter Borg EJ; de Jong PE; Meijer S; Kallenberg CG Nephron; 1989; 53(3):238-43. PubMed ID: 2677808 [TBL] [Abstract][Full Text] [Related]
25. Indomethacin in streptozocin-induced nephrogenic diabetes insipidus. Delaney V; de Pertuz Y; Nixon D; Bourke E Am J Kidney Dis; 1987 Jan; 9(1):79-83. PubMed ID: 2949606 [TBL] [Abstract][Full Text] [Related]
26. Re: The debate regarding the risks of tocolytic agents. Humphrey M; King G Aust N Z J Obstet Gynaecol; 1998 Aug; 38(3):357-8. PubMed ID: 9761179 [No Abstract] [Full Text] [Related]
27. Indomethacin-induced pancreatitis: a case report. Memis D; Akalin E; Yücel T JOP; 2005 Jul; 6(4):344-7. PubMed ID: 16006685 [TBL] [Abstract][Full Text] [Related]
28. [Use of indomethacin and metamizole administered intravenously in renal colic. Comparative study]. Galassi P; Vicentini C; Scapellato F; Laurenti C Minerva Urol; 1983; 35(4):295-300. PubMed ID: 6674754 [No Abstract] [Full Text] [Related]
29. Isolated small bowel perforation following intrauterine treatment with indomethacin. Fejgin MD; Delpino ML; Bidiwala KS Am J Perinatol; 1994 Jul; 11(4):295-6. PubMed ID: 7945625 [TBL] [Abstract][Full Text] [Related]
30. Reversible acute renal insufficiency and hyperkalemia following indomethacin therapy. Galler M; Folkert VW; Schlondorff D JAMA; 1981 Jul; 246(2):154-5. PubMed ID: 7017180 [TBL] [Abstract][Full Text] [Related]
37. Indomethacin therapy in premature infants with patent ductus arteriosus--determination of therapeutic plasma levels. Yeh TF; Achanti B; Patel H; Pildes RS Dev Pharmacol Ther; 1989; 12(4):169-78. PubMed ID: 2766920 [TBL] [Abstract][Full Text] [Related]
38. Green Urine And Altered Mental Status: A Case Of Intoxication. Gangwani MK; Aziz M; Asif R; Ali SA J Ayub Med Coll Abbottabad; 2019; 31(2):278-281. PubMed ID: 31094132 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of adverse renal reactions to prolonged indomethacin therapy in preterm infants with persistent ductus arteriosus. Seyberth HW; Rascher W; Wille L; Hackenthal E; Ulmer HE Pediatr Pharmacol (New York); 1983; 3(3-4):259-66. PubMed ID: 6377215 [TBL] [Abstract][Full Text] [Related]